Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival

BACKGROUND: We sought to develop and validate clinically relevant, early assessment continuous tumor measurement–based metrics for predicting overall survival (OS) using the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 data warehouse. METHODS: Data from 13 trials representing 2096 patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Natl Cancer Inst
Hlavní autoři: An, Ming-Wen, Dong, Xinxin, Meyers, Jeffrey, Han, Yu, Grothey, Axel, Bogaerts, Jan, Sargent, Daniel J., Mandrekar, Sumithra J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4643633/
https://ncbi.nlm.nih.gov/pubmed/26296640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky